Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Reply from Kahlmeter and Giske to Brecher, 'EUCAST and CLSI Point-Counterpoint on Susceptibility Breakpoints: Do Two "I Agree"s Miss the Point?'

Kahlmeter G, Giske CG.

J Clin Microbiol. 2019 Dec 23;58(1). pii: e01519-19. doi: 10.1128/JCM.01519-19. Print 2019 Dec 23. No abstract available.

PMID:
31871059
2.

The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance.

Vandenbroucke-Grauls CMJE, Kahlmeter G, Kluytmans J, Kluytmans-van den Bergh M, Monnet DL, Simonsen GS, Skov RL, Wolff Sönksen U, Voss A.

BMJ Glob Health. 2019 Aug 21;4(4):e001838. doi: 10.1136/bmjgh-2019-001838. eCollection 2019. No abstract available.

3.

Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.

Jarlier V, Diaz Högberg L, Heuer OE, Campos J, Eckmanns T, Giske CG, Grundmann H, Johnson AP, Kahlmeter G, Monen J, Pantosti A, Rossolini GM, van de Sande-Bruinsma N, Vatopoulos A, Żabicka D, Žemličková H, Monnet DL, Simonsen GS; Ears-Net Participants.

Euro Surveill. 2019 Aug;24(33). doi: 10.2807/1560-7917.ES.2019.24.33.1800538.

4.
5.

EUCAST disc diffusion criteria for the detection of mecA-Mediated β-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin.

Skov R, Varga A, Matuschek E, Åhman J, Bemis D, Bengtsson B, Sunde M, Humphries R, Westblade L, Guardabassi L, Kahlmeter G.

Clin Microbiol Infect. 2020 Jan;26(1):122.e1-122.e6. doi: 10.1016/j.cmi.2019.05.002. Epub 2019 May 17.

PMID:
31108230
6.

Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex.

Schön T, Matuschek E, Mohamed S, Utukuri M, Heysell S, Alffenaar JW, Shin S, Martinez E, Sintchenko V, Maurer FP, Keller PM, Kahlmeter G, Köser CU.

Clin Microbiol Infect. 2019 Apr;25(4):403-405. doi: 10.1016/j.cmi.2019.01.019. Epub 2019 Feb 14. No abstract available.

PMID:
30771527
7.

Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections.

Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Kahlmeter G.

JAMA. 2019 Feb 12;321(6):612-613. doi: 10.1001/jama.2018.19345. No abstract available.

PMID:
30747960
8.

[A new SIR definition for antimicrobial susceptibility testing].

Giske C, Hanberger H, Kahlmeter G.

Lakartidningen. 2019 Jan 31;116. pii: FHCX. Swedish.

9.

Developmental roadmap for antimicrobial susceptibility testing systems.

van Belkum A, Bachmann TT, Lüdke G, Lisby JG, Kahlmeter G, Mohess A, Becker K, Hays JP, Woodford N, Mitsakakis K, Moran-Gilad J, Vila J, Peter H, Rex JH, Dunne WM Jr; JPIAMR AMR-RDT Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing.

Nat Rev Microbiol. 2019 Jan;17(1):51-62. doi: 10.1038/s41579-018-0098-9. Review.

PMID:
30333569
10.

MIC-based dose adjustment: facts and fables-authors' response.

Mouton JW, Muller AE, Canton R, G Giske C, Kahlmeter G, Turnidge J.

J Antimicrob Chemother. 2018 Sep 1;73(9):2585-2586. doi: 10.1093/jac/dky195. No abstract available.

PMID:
30137389
11.

Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.

Haldorsen B, Giske CG, Hansen DS, Orri Helgason K, Kahlmeter G, Löhr IH, Matuschek E, Österblad M, Rantakokko-Jalava K, Wang M, Småbrekke L, Samuelsen Ø, Sundsfjord A.

J Antimicrob Chemother. 2018 Oct 1;73(10):2905. doi: 10.1093/jac/dky339. No abstract available.

12.

Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.

Haldorsen B, Giske CG, Hansen DS, Helgason KO, Kahlmeter G, Löhr IH, Matuschek E, Österblad M, Rantakokko-Jalava K, Wang M, Småbrekke L, Samuelsen Ø, Sundsfjord A; NordicAST CPE Study Group.

J Antimicrob Chemother. 2018 Oct 1;73(10):2738-2747. doi: 10.1093/jac/dky276. Erratum in: J Antimicrob Chemother. 2018 Oct 1;73(10):2905.

13.

Epidemiology of fungaemia in Sweden: A nationwide retrospective observational survey.

Klingspor L, Ullberg M, Rydberg J, Kondori N, Serrander L, Swanberg J, Nilsson K, Jendle Bengtén C, Johansson M, Granlund M, Törnqvist E, Nyberg A, Kindlund K, Ygge M, Kartout-Boukdir D, Toepfer M, Hålldin E, Kahlmeter G, Özenci V.

Mycoses. 2018 Oct;61(10):777-785. doi: 10.1111/myc.12816. Epub 2018 Jul 18.

PMID:
29920785
14.

The quality of antimicrobial discs from nine manufacturers-EUCAST evaluations in 2014 and 2017.

Åhman J, Matuschek E, Kahlmeter G.

Clin Microbiol Infect. 2019 Mar;25(3):346-352. doi: 10.1016/j.cmi.2018.05.021. Epub 2018 Jun 7.

PMID:
29886174
15.

Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.

Koeth LM, Matuschek E, Kahlmeter G, Stone G.

Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1047-1053. doi: 10.1007/s10096-018-3215-9. Epub 2018 Mar 30.

PMID:
29603034
16.

Capsule Typing of Haemophilus influenzae by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.

Månsson V, Gilsdorf JR, Kahlmeter G, Kilian M, Kroll JS, Riesbeck K, Resman F.

Emerg Infect Dis. 2018 Mar;24(3):443-452. doi: 10.3201/eid2403.170459.

17.

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group.

Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.

PMID:
29276051
18.
19.

MIC-based dose adjustment: facts and fables.

Mouton JW, Muller AE, Canton R, Giske CG, Kahlmeter G, Turnidge J.

J Antimicrob Chemother. 2018 Mar 1;73(3):564-568. doi: 10.1093/jac/dkx427.

PMID:
29216348
20.

Aerococcus urinae and Aerococcus sanguinicola: Susceptibility Testing of 120 Isolates to Six Antimicrobial Agents Using Disk Diffusion (EUCAST), Etest, and Broth Microdilution Techniques.

Carkaci D, Nielsen XC, Fuursted K, Skov R, Skovgaard O, Trallero EP, Lienhard R, Åhman J, Matuschek E, Kahlmeter G, Christensen JJ.

Open Microbiol J. 2017 Sep 21;11:160-166. doi: 10.2174/1874285801711010160. eCollection 2017.

21.

Colistin antimicrobial susceptibility testing-can the slow and challenging be replaced by the rapid and convenient?

Giske CG, Kahlmeter G.

Clin Microbiol Infect. 2018 Feb;24(2):93-94. doi: 10.1016/j.cmi.2017.10.007. Epub 2017 Oct 21. No abstract available.

22.

EUCAST proposes to change the definition and usefulness of the susceptibility category 'Intermediate'.

Kahlmeter G; EUCAST Steering Committee.

Clin Microbiol Infect. 2017 Dec;23(12):894-895. doi: 10.1016/j.cmi.2017.08.015. Epub 2017 Aug 24. No abstract available.

23.

Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media.

Matuschek E, Åhman J, Kahlmeter G, Yagupsky P.

Clin Microbiol Infect. 2018 Apr;24(4):396-401. doi: 10.1016/j.cmi.2017.07.019. Epub 2017 Jul 29.

24.

Coeliac disease and invasive pneumococcal disease: a population-based cohort study.

Röckert Tjernberg A, Bonnedahl J, Inghammar M, Egesten A, Kahlmeter G, Nauclér P, Henriques-Normark B, Ludvigsson JF.

Epidemiol Infect. 2017 Apr;145(6):1203-1209. doi: 10.1017/S0950268816003204. Epub 2017 Jan 23.

PMID:
28112068
25.

Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey.

Pulcini C, Tebano G, Mutters NT, Tacconelli E, Cambau E, Kahlmeter G, Jarlier V; EUCIC-ESGAP-EUCAST Selective Reporting Working Group.

Int J Antimicrob Agents. 2017 Feb;49(2):162-166. doi: 10.1016/j.ijantimicag.2016.11.014. Epub 2017 Jan 10.

PMID:
28093208
26.

Are breakpoints for phenotypic susceptibility testing no longer needed?

Kahlmeter G, Brown D.

Clin Microbiol Infect. 2017 Jan;23(1):1. doi: 10.1016/j.cmi.2016.11.017. Epub 2016 Nov 29. No abstract available.

27.

The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee.

Ellington MJ, Ekelund O, Aarestrup FM, Canton R, Doumith M, Giske C, Grundman H, Hasman H, Holden MTG, Hopkins KL, Iredell J, Kahlmeter G, Köser CU, MacGowan A, Mevius D, Mulvey M, Naas T, Peto T, Rolain JM, Samuelsen Ø, Woodford N.

Clin Microbiol Infect. 2017 Jan;23(1):2-22. doi: 10.1016/j.cmi.2016.11.012. Epub 2016 Nov 23. Review.

28.

Corrigendum to "The global threat of antimicrobial resistance: science for intervention" [New Microbes New Infect 6 (2015): 22-29].

Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J.

New Microbes New Infect. 2015 Sep 10;8:175. doi: 10.1016/j.nmni.2015.09.004. eCollection 2015 Nov.

29.

Whole-Genome Sequencing for Routine Pathogen Surveillance in Public Health: a Population Snapshot of Invasive Staphylococcus aureus in Europe.

Aanensen DM, Feil EJ, Holden MT, Dordel J, Yeats CA, Fedosejev A, Goater R, Castillo-Ramírez S, Corander J, Colijn C, Chlebowicz MA, Schouls L, Heck M, Pluister G, Ruimy R, Kahlmeter G, Åhman J, Matuschek E, Friedrich AW, Parkhill J, Bentley SD, Spratt BG, Grundmann H; European SRL Working Group.

mBio. 2016 May 5;7(3). pii: e00444-16. doi: 10.1128/mBio.00444-16.

30.

Outbreak of a beta-lactam resistant non-typeable Haemophilus influenzae sequence type 14 associated with severe clinical outcomes.

Andersson M, Resman F, Eitrem R, Drobni P, Riesbeck K, Kahlmeter G, Sundqvist M.

BMC Infect Dis. 2015 Dec 23;15:581. doi: 10.1186/s12879-015-1319-8.

31.

Wide variation in activity of antibiotic discs from nine manufacturers.

Kahlmeter G.

Clin Microbiol Infect. 2016 Mar;22(3):211-2. doi: 10.1016/j.cmi.2015.11.008. Epub 2015 Nov 28. No abstract available.

32.

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.

Niward K, Ängeby K, Chryssanthou E, Paues J, Bruchfeld J, Jureen P, Giske CG, Kahlmeter G, Schön T.

J Antimicrob Chemother. 2016 Feb;71(2):333-8. doi: 10.1093/jac/dkv353. Epub 2015 Nov 3.

PMID:
26538509
33.

Antimicrobial Resistance of Escherichia coli Causing Uncomplicated Urinary Tract Infections: A European Update for 2014 and Comparison with 2000 and 2008.

Kahlmeter G, Åhman J, Matuschek E.

Infect Dis Ther. 2015 Dec;4(4):417-23. doi: 10.1007/s40121-015-0095-5. Epub 2015 Oct 27.

34.

Guidelines need controls.

Raoult D, Hope W, Kahlmeter G.

Clin Microbiol Infect. 2015 Dec;21(12):1043-4. doi: 10.1016/j.cmi.2015.09.010. Epub 2015 Sep 25. No abstract available.

35.

Haemophilus influenzae with Non-Beta-Lactamase-Mediated Beta-Lactam Resistance: Easy To Find but Hard To Categorize.

Skaare D, Lia A, Hannisdal A, Tveten Y, Matuschek E, Kahlmeter G, Kristiansen BE.

J Clin Microbiol. 2015 Nov;53(11):3589-95. doi: 10.1128/JCM.01630-15. Epub 2015 Sep 9.

36.

Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.

Skov R, Matuschek E, Sjölund-Karlsson M, Åhman J, Petersen A, Stegger M, Torpdahl M, Kahlmeter G.

J Clin Microbiol. 2015 Nov;53(11):3411-7. doi: 10.1128/JCM.01287-15. Epub 2015 Aug 19.

37.

The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement?

Kahlmeter G.

J Antimicrob Chemother. 2015 Sep;70(9):2427-39. doi: 10.1093/jac/dkv145. Epub 2015 Jun 18. Review.

PMID:
26089441
38.

Reviving old antibiotics.

Theuretzbacher U, Van Bambeke F, Cantón R, Giske CG, Mouton JW, Nation RL, Paul M, Turnidge JD, Kahlmeter G.

J Antimicrob Chemother. 2015 Aug;70(8):2177-81. doi: 10.1093/jac/dkv157. Epub 2015 Jun 10. Review.

PMID:
26063727
39.

The global threat of antimicrobial resistance: science for intervention.

Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J.

New Microbes New Infect. 2015 Apr 16;6:22-9. doi: 10.1016/j.nmni.2015.02.007. eCollection 2015 Jul. Review. Erratum in: New Microbes New Infect. 2015 Nov;8:175.

40.

Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.

Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, Nicolau DP, Paiva JA, Tumbarello M, Welte T, Wilcox M, Zahar JR, Poulakou G.

Intensive Care Med. 2015 May;41(5):776-95. doi: 10.1007/s00134-015-3719-z. Epub 2015 Mar 20. Review.

PMID:
25792203
41.

Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.

Sturegård E, Ängeby KA, Werngren J, Juréen P, Kronvall G, Giske CG, Kahlmeter G, Schön T.

Clin Microbiol Infect. 2015 Feb;21(2):148.e5-7. doi: 10.1016/j.cmi.2014.08.021. Epub 2014 Oct 29.

42.

Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.

Brown D, Canton R, Dubreuil L, Gatermann S, Giske C, MacGowan A, Martinez-Martinez L, Mouton J, Skov R, Steinbakk M, Walton C, Heuer O, Struelens MJ, Diaz Hogberg L, Kahlmeter G.

Euro Surveill. 2015 Jan 15;20(2). pii: 21008.

43.

Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections.

Kwiecinski J, Kahlmeter G, Jin T.

Curr Microbiol. 2015 May;70(5):698-703. doi: 10.1007/s00284-014-0770-x. Epub 2015 Jan 14.

PMID:
25586078
44.

Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013.

Skaare D, Anthonisen IL, Kahlmeter G, Matuschek E, Natås OB, Steinbakk M, Sundsfjord A, Kristiansen BE.

Euro Surveill. 2014 Dec 11;19(49). pii: 20986.

45.

Within-population distribution of trimethoprim resistance in Escherichia coli before and after a community-wide intervention on trimethoprim use.

Sundqvist M, Granholm S, Naseer U, Rydén P, Brolund A, Sundsfjord A, Kahlmeter G, Johansson A.

Antimicrob Agents Chemother. 2014 Dec;58(12):7492-500. doi: 10.1128/AAC.03228-14. Epub 2014 Oct 6.

46.

Defining antibiotic resistance-towards international harmonization.

Kahlmeter G.

Ups J Med Sci. 2014 May;119(2):78-86. doi: 10.3109/03009734.2014.901446. Review.

47.

Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.

Koeth LM, Matuschek E, Kahlmeter G, Alm RA, Ambler JE.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1511-7. doi: 10.1007/s10096-014-2089-8. Epub 2014 Apr 18.

PMID:
24744220
48.

Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Enterococci with low- and medium-level VanB-type vancomycin resistance: a multicenter study.

Hegstad K, Giske CG, Haldorsen B, Matuschek E, Schønning K, Leegaard TM, Kahlmeter G, Sundsfjord A; NordicAST VRE Detection Study Group.

J Clin Microbiol. 2014 May;52(5):1582-9. doi: 10.1128/JCM.03544-13. Epub 2014 Mar 5.

49.

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.

Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, Kahlmeter G, Pan A, Petrosillo N, Rodríguez-Baño J, Singh N, Venditti M, Yokoe DS, Cookson B; European Society of Clinical Microbiology.

Clin Microbiol Infect. 2014 Jan;20 Suppl 1:1-55. doi: 10.1111/1469-0691.12427. Review.

50.

Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.

Matuschek E, Brown DF, Kahlmeter G.

Clin Microbiol Infect. 2014 Apr;20(4):O255-66. doi: 10.1111/1469-0691.12373. Epub 2013 Oct 17.

Supplemental Content

Loading ...
Support Center